My Vaccine Program (MVP) Combines Best-of-Breed Technologies to Address Consumer Engagement, Vaccine Hesitancy and Safety Surveillance Related to COVID-19
Sandra Garrett, CEO of MediMergent states: âThe MVP engages directly with consumers and captures their attitudes and behaviors related to their health/disease and treatment, in order to improve outcomes. To address vaccine hesitancy, consumers need accurate information regarding the risks/benefits and how people âjust like meâ, with similar health profiles, react to the vaccine. The MVP builds a supportive community, especially for the medically underserved and ethnic and racial minorities.â âDeploying a library of over 250 learning modules, we invite patients to o...
Source: cadillacnews.com